Analysts Just Increased Price Targets of These 10 Stocks

Published June 9, 2022 at 5:05 pm EDT Updated September 7, 2026 at 11:32 am EDT

In this article, we discuss 10 stocks that analysts just increased the price targets of.

The US equity market is in the red today as the initial jobless claims for the week ended on June 4 were reported at their highest level since January. The total number of claims saw an increase of 27000 from the preceding week and exceeded the Dow Jones estimate of 210,000. A rise in the initial jobless claims can be a precursor to an economic downturn. As of 12:12 PM ET, the S&P 500 Index, the Dow 30 Index, and the NASDAQ Composite Index are all down 0.69%, 0.57%, and 0.80%, respectively. Popular stocks such as Meta Platforms, Inc. (NASDAQ:META), Apple Inc. (NASDAQ:AAPL), and Microsoft Corporation (NASDAQ:MSFT) also reported a decline in stock prices.

On the brighter side, analysts increased the price targets of multiple stocks today. Let’s look at why these stocks received upward revisions in price targets and discuss how hedge funds are positioned in them.

10. Couchbase, Inc. (NASDAQ:BASE)

Number of Hedge Fund Holders: 8

Couchbase, Inc. (NASDAQ:BASE) has soared 14.66% as of 12:08 PM ET after the California-based provider of the flexible and scalable modern database for cloud and data centers reported better-than-expected results for Q1 2022. Revenue and loss per share were posted at $34.9 million and 32 cents, respectively, and outperformed the consensus estimate of $32.61 million and 39 cents. For Q2 2022, Couchbase, Inc. expects revenue to be around $35.8 million to $36 million. The midpoint of $35.9 million is $530,0000 higher than the consensus estimate of $35.37 million. Following the positive results, Sangita Singh at Morgan Stanley increased the price target on Couchbase, Inc. from $17 to $18, reflecting an upside potential of 27.2% from the last closing price.

Here’s what Baron Funds said about Couchbase, Inc. in its Q4 2021 investor letter:

“In the fourth quarter, the Fund was down 3.13% versus the Russell 2000 Growth Index, which was roughly unchanged. For the full-year 2021, the Fund was up 4.89% and beat the 2.83% return of the Russell 2000 Growth Index by 2.06%. The lion’s share of the underperformance in the fourth quarter was due to stock selection in the Information Technology (IT) and Health Care sectors. In IT, there was a fairly even spread of winners and losers for the quarter, though IPO profit taking affected Couchbase, Inc. after big third quarter gains.

Couchbase, Inc. provides modern database software that collects and stores data and powers enterprise applications, for which there is no tolerance for disruption, inaccuracy, or downtime. We wrote about our initial investment in this exciting company in our last quarterly letter. Its solution is fast (it utilizes caching, or retrieval from memory versus hard drives), scales to large amounts of records (which is expensive for old-style relational databases, and not even possible with some of the other NoSQL solutions), and works in all settings (on-premise, in the cloud, or in mixed hybrid environments). Couchbase, with revenues of $150 million, is addressing a large total market of $62 billion, which is slowly migrating to the cloud and using less rigid database structures. We added to our investment in the quarter when shares sold off due to multiple compression in the software sector. We believe that the selling was significantly overdone, and Couchbase now sells at a multiple that is about 25% of its main competitor. We believe that on an absolute and relative basis this 25%-plus grower is meaningfully undervalued.”

9. Chart Industries, Inc. (NYSE:GTLS)

Number of Hedge Fund Holders: 29

Chart Industries, Inc. (NYSE:GTLS) received an upward revision in the target price from $175 to $205 by Connor Lynagh at Morgan Stanley. The analyst maintained an Overweight rating on the Georgia-based manufacturer of cryogenic equipment. This is the second upward revision in the price target on Chart Industries, Inc. stock in the last two months by the Morgan Stanley analyst. Chart Industries, Inc. delivered decent Q1 2022 results which were in line with the consensus estimates, and maintained its FY22 outlook. Furthermore, Chart Industries, Inc. has also provided aggressive addressable market forecasts for its equipment.

Chart Industries, Inc. was held by 29 hedge funds at the end of Q1 2022.

8. Cigna Corporation (NYSE:CI)

Number of Hedge Fund Holders: 63

George Hill at Deutsche Bank increased the price target on Cigna Corporation (NYSE:CI) from $236 to $284, reflecting an upside potential of 8.9% from the last closing price. The Bloomfield, Connecticut-based health services company maintained its FY22 outlook before its Investor Day on June 3. Cigna Corporation anticipates annual consolidated revenues of at least $177 billion as opposed to the analysts’ forecast of $178.4 billion. Meanwhile, Cigna Corporation expects adjusted EPS to be at least $22.60, compared to the consensus estimate of $22.73. Going forward, Cigna Corporation anticipates adjusted EPS to grow by 10% – 13% annually.

Cigna Corporation was mentioned in the Q4 2021 investor letter of Davis Funds. Here’s what the firm said:

“Healthcare is included in the portfolio both for company-specific reasons, as well as big picture trends. At the company level, we hold select companies in pharmaceuticals, healthcare services and health insurance at attractive valuations. This is at a time when the average age of the U.S. population is fast approaching 40, older than Asia-Pacific and a little younger than the aged populations of Europe and Japan. The number of seniors in the U.S.—i.e., 65 years or older— now surpasses 54 million, or about 15% of the population. Seniors, on average, take a much greater number of medications and account for a large and disproportionate share of healthcare spending, and we expect that trend to continue due to both raw demographics and a proliferation in the number of available treatments and services available now, the latter being driven by innovation and investment in the healthcare industry. Representative holdings in the Fund include Cigna, United Health Group, Viatris and Quest Diagnostics.”

Overall, 63 hedge funds reported owning a stake in Cigna Corporation at the end of Q1 2022. Renaissance Technologies was the leading hedge fund investor in the company during the first quarter of 2022.

7. Campbell Soup Company (NYSE:CPB)

Number of Hedge Fund Holders: 22

Campbell Soup Company (NYSE:CPB) is up 0.82% as of 12:09 PM ET after Steve Powers at Deutsche Bank increased the price target on the stock from $45 to $48. The analyst reiterated a Hold rating on Campbell Soup Company. Powers sees the company’s Q3 FY22 results as widely solid and was encouraged by the increased sales and the improvement in supply chain-related situations before entering FY23. Despite all these positives, the analyst is neutral on Campbell Soup Company’s stock due to the high level of inflation and uncertainty in demand.

Campbell Soup Company was held by 22 hedge funds as of Q1 2022.

6. Teck Resources Limited (NYSE:TECK)

Number of Hedge Fund Holders: 56

Teck Resources Limited (NYSE:TECK) received an upward revision in the price target from $48 to $52 by Abhi Agarwal at Deutsche Bank. The analyst maintained a Buy rating on the diversified Canadian mining company. The company’s management reiterated that Teck Resources Limited is very close to a transformation as soon as the Quebrada Blanca 2 (QB2) delivers in Chile. This will help Teck Resources Limited reach an inflection point in terms of cash returns and the generation of free cash flow. Agarwal added that Teck Resources Limited is making a shift from a metallurgical coal miner to a base metal miner by 2025. This development could result in a re-rating of the stock.

L1 Capital shared its insights on Teck Resources Limited in its Q4 2021 investor letter. Here’s what the firm said:

“Detailed, bottom-up stock research remains the investment team’s primary focus and the core driver of portfolio performance. 2021 once again demonstrated the team’s ability to identify ‘winners’ through extensive company and industry research across a diverse range of sectors. Key contributors included Teck Resources, (due to its) strong operating performance along with rising copper, coking coal and zinc prices. Construction of one of the world’s largest copper mines (QB2) remains on track.”

In addition to Teck Resources Limited, stocks such as Meta Platforms, Inc., Apple Inc., and Microsoft Corporation are also trending today.

5. Brown-Forman Corporation (NYSE:BF-B)

Number of Hedge Fund Holders: 33

Brown-Forman Corporation (NYSE:BF-B) has soared 1.41% as of 12:09 PM ET after the price target on the Kentucky-based spirits, and wine company was increased from $68 to $72 by Steve Powers at Deutsche Bank. The revision follows the strong Q4 FY22 results posted by Brown-Forman Corporation on June 8. Brown-Forman Corporation reported revenue of $996 million, higher than the consensus estimate of $831.79 million. Meanwhile, the EPS was posted at 31 cents as opposed to the analysts’ forecast of 27 cents.

Here’s what Lindsell Train said about Brown-Forman Corporation in its Q4 2021 investor letter:

“Such growth indicates that it’s not mass market tequila shots driving the boom but rather exquisitely crafted Palomas and complex fine sipping tequilas served over ice or even neat. The global rise of interest in cocktails – itself another indicator of consumer tastes turning towards quality over quantity – has been kind to tequila, with the 2021 Bacardi Global Brand Ambassador Survey placing it as the top trending spirit for 62% of global bartenders (rising to 76% in the US) and tequila-based cocktails now ranking 4 of 30 in popularity. We recognise that trends and “booms” have long been a feature of the spirits market, but arguably the combination of demographic behavioural changes and the increased emphasis on truly differentiated flavours as well as heritage and provenance might make shifts like this more durable than in previous years. So we were impressed with our Global portfolio holding Brown-Forman’s 20% growth in tequila volumes in 2021; and despite raised eyebrows at the 2017 Casamigos purchase price of $1bn, we’re pleased that Diageo owns this superpremium tequila and has managed to grow case sales from just 170,000 in 2017 to 1m in 2020. And even more importantly, I did happen to notice in the course of my, er, extensive research that Casamigos has now been immortalised by Claridge’s in a new cocktail named – what else? – “The George”.”

Of the 912 hedge funds in Insider Monkey’s database, 33 funds held a position in Brown-Forman Corporation as of Q1 2022.

4. Devon Energy Corporation (NYSE:DVN)

Number of Hedge Fund Holders: 66

Devon Energy Corporation (NYSE:DVN) has ascended 0.27% as of 12:11 PM ET after the Oklahoma City-based energy exploration, and production (E&P) company received an increase in price target from John Freeman at Raymond James. The analyst raised the price target on Devon Energy Corporation from $90 to $102, reflecting a potential upside of 30.9% from the previous closing price.

The revision comes a day after the company acquired RimRock Oil and Gas for $865 million. Freeman thinks that the deal will create value for the company with a free cash flow yield of 25% at the current commodity prices. The analyst termed the purchase price as very low. Devon Energy Corporation made a great deal as the purchase price is only 2.2 times the cash flow expected in the next 12 months.

Devon Energy Corporation was held by 66 hedge funds as of Q1 2022.

3. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Number of Hedge Fund Holders: 15

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) has risen 2.64% as of 12:11 PM ET. Jeff Jones at Oppenheimer increased the price target on PMV Pharmaceuticals, Inc. from $30 to $33 and reiterated an Outperform rating on the stock after attending the company’s presentation during the 2022 American Society of Clinical Oncology (ASCO). PMV Pharmaceuticals, Inc. conducted a key opinion leader (KOL) event with Dr. Dumbrava of the University of Texas-based MD Anderson Cancer Center (MDACC). The expert provided positive views on the clinical data.

As of Q1 2022, PMV Pharmaceuticals, Inc. was held by 15 hedge funds.

2. Oxford Industries, Inc. (NYSE:OXM)

Number of Hedge Fund Holders: 15

Oxford Industries, Inc. (NYSE:OXM) has gained 5.31% as of 12:10 PM ET. Paul Lejuez at Citi increased the price target on Oxford Industries, Inc. from $86 to $92 but maintained a Sell rating on the stock. The analyst stated that even though the company posted strong Q1 2022 results, he is skeptical about the performance during the second half of the year. Lejuez expects higher promotions to affect even those companies that are catering to higher-income consumers.

Oxford Industries, Inc. posted revenue and EPS of $352.6 million and $3.50, respectively, as opposed to the analysts’ forecast of $329.02 million and $2.75. Despite inflationary and supply chain-related concerns, Oxford Industries, Inc. provided strong guidance for Q2 2022 and FY22.

Oxford Industries, Inc. was held by 15 hedge funds at the end of Q1 2022.

1. Shoals Technologies Group, Inc. (NASDAQ:SHLS)

Number of Hedge Fund Holders: 16

Shoals Technologies Group, Inc. (NASDAQ:SHLS) has climbed 4% as of 12:11 PM ET after the Tennessee-based provider of Electrical Balance of System (EBOS) components for solar solutions was upgraded from a Hold to a Buy rating by Bronson Fleig at Truist. The analyst also increased the price target on Shoals Technologies Group, Inc. from $16 to $25. Fleig thinks that the two-year tariff exemption on solar imports will support the core EBOS business of Shoals Technologies Group, Inc.. The EBOS is utilized for large-scale, utility solar projects in the US, and the tariff exemption news has given the stock price an increased momentum. The analyst is also optimistic about the Shoals Technologies Group, Inc.’s prospects outside the US and its non-solar EBOS business.

Shoals Technologies Group, Inc. was discussed in the Q2 2021 investor letter of ClearBridge Investments. Here’s what the firm said:

“Our largest new addition was Shoals Technologies, in the industrials sector, which manufactures electric balance of systems (EBOS) components for ground-mounted solar projects. The company has IP protection around a system of EBOS installation that does not rely on licensed electricians for installation and can be installed above ground, thereby offering the customer significant time and labor savings.”

As of Q1 2022, Shoals Technologies Group, Inc. was held by 16 hedge funds.

You can also take a peek at the 10 Best Long-Term Dividend Stocks with Over 4% Yield and 10 Oil Tanker Stocks That Pay Dividends.

Follow Insider Monkey on Twitter